Bank of America Raises Option Care Health (NASDAQ:OPCH) Price Target to $35.00

Option Care Health (NASDAQ:OPCH) had its target price upped by equities research analysts at Bank of America from $32.00 to $35.00 in a report released on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Bank of America‘s target price would suggest a potential upside of 5.77% from the stock’s previous close.

A number of other analysts have also recently commented on OPCH. TD Cowen dropped their price target on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating on the stock in a research note on Monday, November 3rd. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday. Morgan Stanley assumed coverage on Option Care Health in a research report on Friday, October 17th. They set an “overweight” rating and a $35.00 target price on the stock. Citigroup reiterated an “outperform” rating on shares of Option Care Health in a research report on Friday, October 31st. Finally, Citizens Jmp decreased their price objective on Option Care Health from $38.00 to $36.00 and set a “market outperform” rating on the stock in a research note on Friday, October 31st. Eleven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $36.27.

Option Care Health Trading Up 2.7%

Shares of Option Care Health stock opened at $33.09 on Tuesday. The stock has a market capitalization of $5.25 billion, a P/E ratio of 26.26, a P/E/G ratio of 2.27 and a beta of 0.80. Option Care Health has a 52-week low of $22.29 and a 52-week high of $35.53. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.05 and a current ratio of 1.56. The stock’s 50-day simple moving average is $28.52 and its 200 day simple moving average is $29.32.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of Option Care Health stock in a transaction that occurred on Monday, November 3rd. The stock was acquired at an average cost of $25.98 per share, for a total transaction of $987,240.00. Following the completion of the transaction, the director directly owned 413,390 shares in the company, valued at $10,739,872.20. This represents a 10.12% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

A number of large investors have recently modified their holdings of the business. Teton Advisors Inc. increased its position in shares of Option Care Health by 2.2% in the second quarter. Teton Advisors Inc. now owns 17,368 shares of the company’s stock worth $564,000 after purchasing an additional 368 shares during the last quarter. US Bancorp DE increased its holdings in shares of Option Care Health by 5.0% in the 1st quarter. US Bancorp DE now owns 8,199 shares of the company’s stock worth $287,000 after buying an additional 393 shares during the last quarter. Assetmark Inc. raised its position in shares of Option Care Health by 1.6% during the 2nd quarter. Assetmark Inc. now owns 26,690 shares of the company’s stock valued at $867,000 after buying an additional 416 shares in the last quarter. State of Wyoming lifted its holdings in shares of Option Care Health by 1.8% during the 2nd quarter. State of Wyoming now owns 25,135 shares of the company’s stock worth $816,000 after acquiring an additional 436 shares during the last quarter. Finally, Sheets Smith Wealth Management lifted its holdings in shares of Option Care Health by 1.9% during the 2nd quarter. Sheets Smith Wealth Management now owns 24,938 shares of the company’s stock worth $810,000 after acquiring an additional 457 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.